McDermott Will & Schulte represents Warburg Pincus in investor group acquisition of PANTHERx Rare | McDermott

McDermott Will & Schulte, a global law firm

DEAL ANNOUNCEMENT

McDermott Will & Schulte represents Warburg Pincus in investor group acquisition of PANTHERx Rare

Jul 14, 2026

Read time: 2 min

Global law firm McDermott Will & Schulte advised Warburg Pincus, the pioneer of global growth investing, in a Warburg Pincus-led investor group acquisition of a controlling interest in PANTHERx Rare, the leading independent rare pharmacy in the United States, from Nautic Partners, General Atlantic, and The Vistria Group.

The investment will support PANTHERx as a category-defining rare disease care platform while preserving its patient-first and manufacturer-aligned model. The companies expect to close the transaction in the coming months.

The McDermott team was led by Joel Rush and Joe Parise with invaluable assistance from Callee Donovan, Emily Curran, Brian Hall, Lauren Ellison, Jamie Gelfman, Maggie Houtz, Matt Perreault, and Drew McCormick.

Read the Warburg Pincus press release here.

In this article

Joel C. Rush

Partner

Washington, DC

Joseph M. Parise

Partner

Boston

Callee Donovan

Associate

Boston

Emily R. Curran

Associate

Washington, DC

M. Brian Hall ,IV

Partner

Washington, DC

Lauren Ellison

Associate

Washington, DC

Jamie B. Gelfman

Partner

Miami

Margaret Houtz

Associate

Boston

You may also like